Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cognition-enhancing effects of new nAChR alpha7 partial agonist tested in monkeys

Nov. 12, 2007

Canadian researchers report an SOD1-targeted immunotherapeutic approach to familial ALS

Nov. 12, 2007

Meditor completes primary endpoint and safety evaluation in phase II study of MTR-106

Nov. 12, 2007

New agents for treating neurological disorders disclosed in recent patents

Nov. 12, 2007

Recent PainCeptor and Boehringer Ingelheim patents disclose novel analgesic agents

Nov. 12, 2007

FDA approves Abilify for adolescent patients aged 13-17 years with schizophrenia

Nov. 9, 2007

In vitro and in vivo activity of new 5-HT2C inverse agonist characterized in San Diego

Nov. 9, 2007

Abbott characterizes novel analgesic CB2 receptor agonist

Nov. 9, 2007

Dual H3 antagonist/SERT inhibitor in development at J&J for depression

Nov. 9, 2007

Systemically administered calpain inhibitor effective in animal models of SAH

Nov. 9, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...